Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity (Unaudited)

v3.22.1
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained earnings
Accumulated other comprehensive income
Beginning Balance at Dec. 31, 2020 $ 349,623 $ 22 $ 273,521 $ 75,605 $ 475
Beginning Balance, shares at Dec. 31, 2020   22,131,447      
Stock-based compensation 2,516   2,516    
Employee stock purchases 927   927    
Employee stock purchases, shares   37,699      
Restricted stock awards issued, net of forfeitures, shares   (21,509)      
Vesting of restricted stock units (275)   (275)    
Vesting of restricted stock units, shares   34,117      
Shares withheld related to net restricted stock settlement (91)   (91)    
Shares withheld related to net restricted stock settlement, shares   (1,713)      
Stock options exercised 3,866   3,866    
Stock options exercised, shares   205,753      
Net loss (732)     (732)  
Other comprehensive income (loss) 450       450
Ending Balance at Mar. 31, 2021 356,284 $ 22 280,464 74,873 925
Ending Balance, shares at Mar. 31, 2021   22,385,794      
Beginning Balance at Dec. 31, 2021 370,227 $ 23 299,463 69,272 1,469
Beginning Balance, shares at Dec. 31, 2021   22,731,586      
Stock-based compensation 2,665   2,665    
Employee stock purchases 915   915    
Employee stock purchases, shares   30,558      
Vesting of restricted stock units (958)   (958)    
Vesting of restricted stock units, shares   73,495      
Shares withheld related to net restricted stock settlement (94)   (94)    
Shares withheld related to net restricted stock settlement, shares   (2,666)      
Stock options exercised $ 29   29    
Stock options exercised, shares 3,499 3,499      
Net loss $ (14,214)     (14,214)  
Other comprehensive income (loss) (285)       (285)
Ending Balance at Mar. 31, 2022 $ 358,285 $ 23 $ 302,020 $ 55,058 $ 1,184
Ending Balance, shares at Mar. 31, 2022   22,836,472